CEimpact Podcast

A Guideline Review for Osteoporosis

February 06, 2023 CEimpact
CEimpact Podcast
A Guideline Review for Osteoporosis
Show Notes

Osteoporosis may be a forgotten disease – common but rarely treated. The 2023 guidelines are not here. Join host, Geoff Wall, as he reviews the new treatment recommendations and how we can optimize pharmacotherapy for all persons with osteoporosis.

The GameChanger
Osteoporosis is common and routine screenings should be implemented. Bisphosphonates are still the drug of choice, but treatment for persons over 65 should be made on a case-by-case basis.

Show Segments
00:00 - Introduction
00:25 - Background on Osteoporosis
04:17 - How Guidelines Are Formed
08:45 - Bisphosphonate Recommendation
14:14 - Denosumab Recommendation
16:40 - Anabolic Drugs
20:40 - SERMs
22:24 - The GameChanger: Recommendations Summary
27:20 - Closing Remarks

Geoff Wall, PharmD, BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

References and Resources

Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians.

FRAX Calculator

Redeem your CPE here
CPE (Pharmacist)

Get a membership & earn CE for GameChangers Podcast episodes (30 mins/episode)
Pharmacists: Get a membership

CE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the epidemiology and diagnosis of osteoporosis
2. Apply the treatment guidelines for osteoporosis to a specific patient

0.05 CEU/0.5 Hr
UAN: 0107-0000-23-063-H01-P
Initial release date: 01/06/2023
Expiration date: 01/06/2024
Additional CPE and CME details can be found here.

Follow CEimpact on Social Media: